Literature DB >> 32460996

Locally advanced squamous cell carcinoma of the vulva: A challenging question for gynecologic oncologists.

Angiolo Gadducci1, Giovanni Damiano Aletti2.   

Abstract

Squamous cell carcinoma of the vulva is a rare female malignancy, with an incidence increasing with age. Unfortunately, one third of the patients are diagnosed with locally advanced disease, which constitutes a clinical challenge for the clinicians who treat these patients. The main challenges are represented by: 1. The primary site of the disease, which can be proximal to anatomical structures like the anal canal posteriorly, or the urethra and the bladder anteriorly, that in some circumstances cannot be spared without a bowel and/or urinary stoma; 2. The locoregional nodes that can be involved by the tumor, and they can be bulky, fixed or ulcerated; 3. The clinical condition of the patient, who may carry several comorbidities. Treatment modalities include radiation with or without chemotherapy, and surgery. In order to preserve the bowel and the urinary function without a permanent stoma, a personalized management with a multimodality approach is warranted. In this systematic review, we first clarify the different definitions of "locally advanced vulvar carcinoma". Secondly, we evaluated the different treatment modalities described in the literature, and the impact of the different treatment strategies on prognosis and on preservation of bowel/urinary function. Finally, we offer a possible algorithm that may help the clinicians in treating patients with these uncommon and challenging situations with a multidisciplinary approach.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemoradiotherapy; Chemotherapy; Radiotherapy; Surgery; Vulvar cancer

Year:  2020        PMID: 32460996     DOI: 10.1016/j.ygyno.2020.05.021

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Perineural Invasion Correlates With Common Pathological Variables and Clinical Outcomes of Patients With Squamous Cell Carcinoma of the Vulva Treated With Primary Radical Surgery and Inguinal-femoral Lymphadenectomy.

Authors:  Angiolo Gadducci; Sabina Pistolesi; Stefania Cosio; Chiara Comunale; Antonio Fanucchi; Antonio Giuseppe Naccarato
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 2.  MRI in the Evaluation of Locally Advanced Vulvar Cancer Treated with Chemoradiotherapy and Vulvar Cancer Recurrence: The 2021 Revision of FIGO Classification and the Need for Multidisciplinary Management.

Authors:  Maura Miccò; Luca Russo; Salvatore Persiani; Miriam Dolciami; Lucia Manganaro; Teresa Margarida Cunha; Catarina Janicas; Stefania Rizzo; Olivera Nicolic; Giorgia Garganese; Luca Tagliaferri; Valentina Lancellotta; Giovanni Scambia; Riccardo Manfredi; Benedetta Gui
Journal:  Cancers (Basel)       Date:  2022-08-09       Impact factor: 6.575

Review 3.  Current Surgical Therapy of Locally Advanced cSCC: From Patient Selection to Microsurgical Tissue Transplant. Review.

Authors:  Tito Brambullo; Gian Paolo Azzena; Paolo Toninello; Giuseppe Masciopinto; Alberto De Lazzari; Bernardo Biffoli; Vincenzo Vindigni; Franco Bassetto
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.